Eko, the company that’s responsible for the Eko CORE digital stethoscope we highly praised, is now releasing an interesting new device that provides ECG and auscultation capabilities in a mobile package. The Eko DUO looks a bit like a cell phone from the 1990’s, but with only three buttons on its body. When held against the chest, it provides both a 1-lead ECG and auscultation comparable to a standard stethoscope.

The device can be used by clinicians or by patients themselves. As a clinical tool, it can work just like a typical stethoscope, featuring a 3.5 mm audio jack on the bottom that can accept headphones, external speakers, or a traditional stethoscope earpiece that comes along in the product box.

If used remotely by the patients, the heart and lung sounds, as well as the ECG chart, can be easily shared with their doctors via the accompanying Eko app. The sounds and ECG readings are recorded simultaneously, and are shown synchronized together within the HIPAA compliant app. The data can also be transferred into a hospitals electronic medical records (EMR) to keep on file in case further review is necessary.

The DUO features wireless charging, as it’s simply placed on top of an accompanying charging pad whenever the batteries start to run low. Of note, a single charge is sufficient for about nine hours of continuous vitals recording and to help increase that, the DUO automatically shuts down after five minutes of not being used.

The digital stethoscope amplifies sounds up to sixty times and comes with built-in noise reduction, as well as four digital audio filters (diaphragm, bellmode, midrange, and extended). The ECG works at 500 Hz sampling resolution, the signals passing through a .01 Hz high pass filter and through a selectable 50 or 60 Hz mains filter.

This is certainly an interesting product, and having been impressed by the Eko CORE stethoscope.

At Cardiac Care and OCC Health we are using the Eko CORE technology with all our patients to detect any heart or cardiopulmonary problems.

Share with

Back to Blog

OCC’s epidemiologist is closely monitoring the COVID-19 status and is actively issuing updates as they are available. The Centers for Disease Control and the World Health Organization are the most trusted sources online.  While the CDC has announced new mask protocols for vaccinated individuals, there will be no changes for our office protocols for patients, guests, and staff members as the announcement does not apply to hospitals or medical facilities. Masks are still a requirement for all patients, guests and staff at our facility.

As we reinitiate weight loss surgery, we are constantly adapting and installing new and updated safety measures.

Weight loss surgery is medically necessary.

Bariatric Surgery and the clash of two pandemics.   

Major metabolic and bariatric surgery Societies and colleges globally are now calling for the safe resumption of bariatric and metabolic surgery before the COVID-19 pandemic is declared over. 

The sooner bariatric surgery can be safely performed, the quicker obesity, type 2 diabetes, and other diseases can be reduced or resolved as they are not only chronic they are also progressive.  Obesity is also linked to more than 40 diseases including type 2 diabetes, hypertension, heart disease, stroke, sleep apnea, osteoarthritis, and at least 13 different types of cancer.

A recent statement from the ASMBS says “Before COVID-19 began, it was clear that patients with obesity were ‘safer through surgery.’ In the era of COVID-19, ‘safer through surgery’ for patients with obesity may prove to be even more important than before.” Obesity and Metabolic syndrome have been identified as an independent risk factor for adverse outcomes including death among COVID-19 patients.

See here for full COVID-19 update. 

Contact us media
Contact Us
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at 866-675-9912.
Contact Us